Plant closure as Micro Therapeutics focuses on US:
This article was originally published in Clinica
Micro Therapeutics has laid off 60 workers and closed its facility in Bochum, Germany, shifting all production to its headquarters in Irvine, California. The company, which makes catheter and interventional neuroradiology products, says the move is designed to cut manufacturing and overhead costs, and improve customer services. It will incur fourth-quarter one-off charges of $2.5-3.5m as a result of the closure.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.